Ear Pain Md For Kids Liquid
NDC Package 72429-0002-9
Package Information
Ear Pain Md For Kids (lidocaine hydrochloride) liquids is adults and children 2 years and overApply 2 to 3 drops to affected area not more than 3 to 4 times daily.Children under 2 yearsConsult a doctor. This formulation utilizes a liquid delivery system. Marketed by Eosera Inc, this product is identified by NDC 72429-0002 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 2595042 - lidocaine HCl 4 % Otic Solution
- RxCUI: 2595042 - lidocaine hydrochloride 40 MG/ML Otic Solution
- RxCUI: 2595042 - lidocaine hydrochloride 4 % Otic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72429 - Eosera Inc
- 72429-0002 - Ear Pain Md For Kids
- 72429-0002-9 - 1 BOTTLE, DROPPER in 1 CARTON / 12.5 mL in 1 BOTTLE, DROPPER
- 72429-0002 - Ear Pain Md For Kids
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (72429-0002). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72429-0002-9 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 12.5 ml in 1 bottle, dropper of Ear Pain Md For Kids, a human over the counter drug labeled by Eosera Inc. This liquid is formulated for topical use and contains lidocaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Eosera Inc on January 24, 2022. The current certification is valid through December 31, 2026.
How is this Eosera Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72429000209. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.